文献速递皮肤肿瘤

器官移植受者角质形成细胞癌发病率下降

Declining incidence of keratinocyte carcinoma in organ transplant recipients.
PubMed 文献 · Br J Dermatol · 2019-01-01

BACKGROUND: All organ transplant populations are predisposed to increased rates of keratinocyte carcinoma (KC). Since this increased risk was first appreciated, immunosuppressive regimens have changed and organ transplant recipients (OTRs) have been aggressively screened for KC.…

要点

  • 实体器官移植受者SCC和BCC的标准化发病率比在二十年间显著下降。
  • SCC与BCC比值维持3:1,提示两者下降幅度相当。
  • 下降趋势与免疫抑制方案变化及皮肤癌预防项目引入同步。

核心结论

  • 实体器官移植后SCC和BCC的发病率在近二十年间显著下降。
  • SCC与BCC比值维持3:1,表明两者下降程度相似。

研究设计与样本

  • 全国性人群研究纳入1994至2014年移植的3580例实体器官移植受者。

主要发现

  • SCC与BCC比值在过去二十年维持3:1。

临床怎么用

  • 移植受者仍需持续进行皮肤癌筛查和预防管理。
  • 免疫抑制方案的变化可能与皮肤癌风险下降相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: All organ transplant populations are predisposed to increased rates of keratinocyte carcinoma (KC). Since this increased risk was first appreciated, immunosuppressive regimens have changed and organ transplant recipients (OTRs) have been aggressively screened for KC. There is a perception that these measures have impacted on KC incidence but there is a paucity of population-based studies on post-transplant rates of basal cell carcinoma (BCC). OBJECTIVES: To identify trends in incidence rates for KC following solid organ transplantation over the past two decades. METHODS: This nationwide, population-based study included all solid OTRs transplanted between 1994 and 2014. Patient data were matched to national cancer registry data to determine the standardized incidence ratio (SIR) of KC in solid OTRs compared with the general population. RESULTS: In total 3580 solid OTRs were included. The total follow-up time was 28 407 person-years (median follow-up 7·11 years). The overall SIRs for squamous cell carcinoma (SCC) and BCC were 19·7 and 7·0, respectively. Our study documents a progressive fall in the SIRs for SCC and BCC from peak SIRs (95% confidence intervals) in 1994-1996 of 26·4 (21·5-32·4) and 9·1 (7·4-11·3) to 6·3 (2·3-16·7) and 3·2 (1·4-7·1) in 2012-2014, respectively. The ratio of SCC to BCC has remained at 3 to 1 over the last two decades. CONCLUSIONS: Our study is the first to demonstrate a significant reduction over the past two decades in the incidences of both SCC and BCC following solid organ transplantation. The SCC-to-BCC ratio was maintained, demonstrating that both are reducing equally. This trend coincided with temporal changes in immunosuppressive protocols and the introduction of skin cancer prevention programmes. What's already known about this topic? Prior studies have shown that the risk of cutaneous squamous cell carcinoma (SCC) has declined over recent decades following solid organ transplantation. It is not known whether the risk of basal cell carcinoma (BCC) has reduced in line with this. What does this study add? Our study documents a progressive fall in the risk of SCC and BCC following solid organ transplantation over the last two decades. The SCC-to-BCC ratio was maintained, demonstrating that both are reducing equally. The trends observed in our study coincided with temporal changes in immunosuppressive protocols and the introduction of cancer prevention programmes, suggesting that these factors have positively impacted on the risk of keratinocyte carcinoma in this cohort.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Menzies S, O'Leary E, Callaghan G, et al. Declining incidence of keratinocyte carcinoma in organ transplant recipients. Br J Dermatol. 2019. PMID: 31049932. doi:10.1111/bjd.18094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。